You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune therapy pre-treated

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Squamous Cell Skin Carcinoma Trial (Ad-MAGEA3, MG1-MAGEA3, Pembrolizumab)

Withdrawn
  • Metastatic Melanoma
  • Squamous Cell Skin Carcinoma
  • (no location specified)
Apr 1, 2021

Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

Recruiting
  • Cytokine Release Syndrome
  • Miami, Florida
  • +9 more
Oct 25, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

Not yet recruiting
  • Stage IV NSCLC
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Sep 28, 2023

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022

Hepatocellular Carcinoma Trial in Toronto, Milan, Pamplona (Tremelimumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +2 more
Jun 27, 2022

Immune Checkpoint Inhibitors Nephrotoxicity

Recruiting
  • Kidney Injury
  • Antineoplastics Toxicity
  • Early kidney damage biomarkers
  • Predisposition to kidney injury biomarkers
  • Salamanca, Spain
  • +1 more
Jul 26, 2022

Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3 Trial in Netherlands

Recruiting
  • Cervical High Grade Squamous Intraepithelial Lesion
  • +3 more
  • Breda, Netherlands
  • +12 more
Jun 21, 2022

Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Recruiting
  • Graft Rejection
  • +3 more
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
Jun 21, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Tucson (Cabozantinib + Atezolizumab)

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Cabozantinib + Atezolizumab
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 14, 2022

Responsiveness in Oncology Patients Based on Host Response

Recruiting
  • Non Small Cell Lung Cancer
  • Healthy
  • blood, stool and tissue samples collection
  • Dallas, Texas
    Baylor Scott and White Research Institute
Feb 9, 2023

Immune System Diseases Trial (Strimvelis)

Withdrawn
  • Immune System Diseases
  • Strimvelis
  • (no location specified)
Jul 13, 2020

Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

Recruiting
  • Cancer Patients
  • Low-dose radiotherapy combined with conventional fractionated radiotherapy
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023

Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)

Recruiting
  • Multiple Myeloma
  • TAA-specific CTLs
  • TAA-specific CTLs- fixed dose
  • Houston, Texas
    Houston Methodist Hospital
Nov 11, 2022

Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • IRE plus checkpoint inhibitor
  • IRE plus Checkpoint Inhibitor plus CpG-ODN
  • (no location specified)
Sep 13, 2023

Anti-cancer Immune Checkpoint Inhibition TowardsBetter

Not yet recruiting
  • Cancer
    • (no location specified)
    Aug 1, 2023

    Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

    Not yet recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer
    • (no location specified)
    Nov 10, 2023

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Recurrent Glioblastoma Trial (Atezolizumab)

    Not yet recruiting
    • Recurrent Glioblastoma
    • (no location specified)
    Oct 3, 2023

    Viral Wart Trial in Haifa (Long-Pulsed Nd:YAG Laser 1064nm & Er:YAG Laser 2940nm, Er:YAG Laser 2940nm)

    Completed
    • Viral Wart
    • Long-Pulsed Nd:YAG Laser 1064nm & Er:YAG Laser 2940nm
    • Er:YAG Laser 2940nm
    • Haifa, Israel
      Rambam Health Care Campus
    Mar 14, 2023

    Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Brussels, Kortrijk, Namur (drug, radiation, procedure)

    Active, not recruiting
    • Rectal Cancer Stage II
    • Rectal Cancer Stage III
    • Nivolumab 10 MG/ML Intravenous Solution
    • +3 more
    • Brussels, Belgium
    • +3 more
    Jul 11, 2022

    NSCLC, Immune Checkpoint Inhibitors Trial in Seoul (F-18 FDG PET/CT)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Immune Checkpoint Inhibitors
    • F-18 FDG PET/CT
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 15, 2022

    Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)

    Not yet recruiting
    • Actinic Keratosis
    • Biopsy
    • +2 more
    • Tucson, Arizona
    • +3 more
    Jan 25, 2023

    Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

    Recruiting
    • Urothelial Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Breast Cancer Trial in Italy (Epirubicin, Cyclophosphamide, Triptorelin)

    Completed
    • Breast Cancer
    • Cona, FE, Italy
    • +4 more
    Dec 2, 2020